Sign in

CIK 0001021561

  • Accelerated filer

NU SKIN ENTERPRISES, INC.

Sign in to watch
Ticker
NUS
Exchange
NYSE
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870565309
Phone
+1 801-345-1000
Business address
75 WEST CENTER ST, ATTN: GREGORY BELLISTON, PROVO, UT, 84601
Former names
NU SKIN ENTERPRISES INC, NU SKIN ASIA PACIFIC INC, NU SKIN ASIA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-13 LUND STEVEN Exec. Chairman of the Board Sale −2,927 $44.47 $130K 140,949
2022-06-13 LUND STEVEN Exec. Chairman of the Board Sale −11,581 $43.85 $508K 28,419
2022-06-13 LUND STEVEN Exec. Chairman of the Board Sale −1,219 $44.50 $54K 27,200
2022-06-08 WOODBURY EDWINA D Director Grant or award +13 $46.52 $605 16,680
2022-06-06 Lawrence Mark H Chief Financial Officer Sale −5,868 $47.03 $276K 48,218
2022-06-05 Clark Chayce David EVP and General Counsel Shares withheld for taxes −649 $46.91 $30K 22,892
2022-06-05 Hatchett Steven Keith Chief Product Officer Shares withheld for taxes −464 $46.91 $22K 54,931
2022-06-02 CAMPBELL DANIEL W Director Grant or award +3,179 14,692
2022-06-02 Battle Emma S. Director Grant or award +3,179 5,646
2022-06-02 WOODBURY EDWINA D Director Grant or award +3,179 16,667
2022-06-02 Shen Zheqing Director Grant or award +3,179 17,633
2022-06-02 Thomas Pisano R. Director Grant or award +3,179 56,614
2022-06-02 Nathanson Laura Director Grant or award +3,179 12,136
2022-06-02 LIPMAN ANDREW D Director Grant or award +3,179 73,393
2022-06-01 CHANG JOSEPH Y Chief Scientific Officer Exercise or conversion +16,000 $30.63 $490K 38,957
2022-06-01 CHANG JOSEPH Y Chief Scientific Officer Sale −8,975 $46.25 $415K 29,982
2022-06-01 CHANG JOSEPH Y Chief Scientific Officer Sale −7,025 $46.97 $330K 22,957
2022-06-01 CHANG JOSEPH Y Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) −16,000 26,600
2022-05-25 NAPIERSKI RYAN S President and CEO Exercise or conversion +13,000 $37.58 $489K 135,683
2022-05-25 NAPIERSKI RYAN S President and CEO Exercise or conversion +12,000 $30.63 $368K 147,683

Page 13 of 15 · 288 trades